Tagviral load

Watch on-demand: Sessions from the 1st Australasian Conference on Point of Care Testing

W

Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), 26/04/2023 The inaugural 1st Australasian Conference on Point of Care Testing for Infectious Diseases was an outstanding achievement. Hosted at the Sheraton Grand Sydney Hyde Park on the 14th and 15th of March, the conference attracted over 270 attendees from 19 different countries, representing numerous disciplines...

Can hepatitis C be transmitted to a foetus?

C

Medical News Today,  Medically reviewed by Carolyn Kay M.D. & Written by Zia Sherrell MPH, May 13, 2021 The hepatitis C virus (HCV) can transmit to a fetus during pregnancy, but the risk of this happening is low. And if the transmission occurs, the baby’s immune system may clear the virus on its own. If the baby’s immune system does not clear the virus, there are safe and effective treatments...

FDA Approves Cabenuva, the First Complete Long-Acting Injectable HIV Treatment

F

Poz.com, January 21, 2021 On January 21, the Food and Drug Administration (FDA) in the USA approved the first complete injectable HIV treatment regimen that does not require daily pills. Cabenuva, from ViiV Healthcare, is administered only once a month. It is approved for people with an undetectable viral load on their current therapy who wish to switch to a long-acting regimen. Cabenuva consists...

U = U: awareness and associations with health outcomes among PLHIV in 25 countries

U

Okoli C, Van de Velde N, Richman B, et al Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries Sexually Transmitted Infections  Published Online First: 30 July 2020. doi: 10.1136/sextrans-2020-054551 Abstract: Objectives ‘Undetectable equals Untransmittable’ (U=U) is an empowering message that may enable people...

Case report: HIV-associated neurocognitive disorder & myelopathy in patient with preserved CD4, but high viral load

C

HIV-associated neurocognitive disorder and HIV-associated myelopathy in a patient with a preserved CD4, but high viral load-a rarely reported phenomenon: a case report and literature review.  Ayele, B.A., Amogne, W. & Gemechu, L. BMC Infect Dis 20, 574 (2020). This case supports the current understanding regarding the persistent occurrence of HIV-associated neurocognitive disorder and HIV...

Coronavirus disease (COVID-19), HIV & hepatitis C: What you need to know

C

CATIE (Canada), 17 March 2020 An HIV-positive person on effective treatment is not expected to be at higher risk of becoming seriously ill with COVID-19 A person with untreated HIV or a low CD4+ cell count may be at higher risk of becoming seriously ill with COVID-19 People with HIV or hepatitis C are more likely to have other conditions that carry a greater risk of becoming seriously ill with...

Your sidebar area is currently empty. Hurry up and add some widgets.